2-piperazin-1-yl-6-(trifluoromethoxy)-1,3-benzothiazole, 95.0%, 250mg

N-(4-(N-(Thiazol-2-yl)sulfamoyl)phenyl)acetamide, 95%, 1g

1-(1-piperidinyl)cyclohexanecarboxylic acid hydrochloride, 95.0%, 1g

METHYL 2-(BROMOMETHYL)-3-(TRIFLUOROMETHYL)BENZOATE, 95.0%, 1g

Tert-butyln-[(1r,2s)-1-ethyl-2-hydroxy-propyl]carbamate, 98%, 500mg

Rubidium molybdate powder 99.5% -200 mesh 25 g

1,4-Dihydroxynaphthalene>98.0%(GC)25g

2-Butanol>99.0%(GC)25mL

4-Chloro-2H-chromen-2-one, 97%, 25g

2-(2-Methylcyclohexylidene)propanedinitrile, 100mg

Phenolphthalin [for redox indicator]>98.0%(HPLC)(T)25g

3,7-DIBROMOIMIDAZO[1,2-A]PYRIDINE, 90.0%, 250mg

N,O-Bis(trimethylsilyl)trifluoroacetamide Kit BSTFA 1 mL * 8 / Reaction vial, capacity 2 mL * 81kit